OOIR: Observatory of International Research

Papers

(The H4-Index of American Journal of Physiology-Cell Physiology is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Adipose tissue inflammation and metabolic dysfunction in obesity	727
Long-term complications of COVID-19	243
Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19	157
The H⁺-ATPase (V-ATPase): from proton pump to signaling complex in health and disease	93
Single-cell transcriptomic analysis identifies extensive heterogeneity in the cellular composition of mouse Achilles tendons	78
Neuroendocrine signaling in the skin with a special focus on the epidermal neuropeptides	77
Molecular nature and physiological role of the mitochondrial calcium uniporter channel	77
In vitro and ex vivo models of adipocytes	73
Heterogeneity within molecular subtypes of breast cancer	65
The intersection of metformin and inflammation	60
Tenascin-C in cardiac disease: a sophisticated controller of inflammation, repair, and fibrosis	54
Disuse-induced skeletal muscle atrophy in disease and nondisease states in humans: mechanisms, prevention, and recovery strategies	52
Cellular metabolomics of pulmonary fibrosis, from amino acids to lipids	48
Factors mediating spaceflight-induced skeletal muscle atrophy	46
Extracellular vesicle secretion is tissue-dependent ex vivo and skeletal muscle myofiber extracellular vesicles reach the circulation in vivo	45
Soluble ACE2 as a potential therapy for COVID-19	44
Is REDD1 a metabolic double agent? Lessons from physiology and pathology	42
Mitochondrial redox regulation and myocardial ischemia-reperfusion injury	41
Aerobic exercise and resistance exercise alleviate skeletal muscle atrophy through IGF-1/IGF-1R-PI3K/Akt pathway in mice with myocardial infarction	40
The glycosaminoglycan interactome 2.0	39
Cell physiology and molecular mechanism of anion transport by erythrocyte band 3/AE1	39
TRPV4-Rho signaling drives cytoskeletal and focal adhesion remodeling in trabecular meshwork cells	38
Endothelial upregulation of mechanosensitive channel Piezo1 in pulmonary hypertension	38
Drivers of dynamic intratumor heterogeneity and phenotypic plasticity	36
Role of glypican-1 in regulating multiple cellular signaling pathways	35

Muscle-nerve communication and the molecular assessment of human skeletal muscle denervation with aging	35
The microRNA-29 family: role in metabolism and metabolic disease	34
Mechanisms and mathematical modeling of ROS production by the mitochondrial electron transport chain	34
Translating the force—mechano-sensing GPCRs	34
The CD38 glycohydrolase and the NAD sink: implications for pathological conditions	34
Mitochondrial DNA damage as driver of cellular outcomes	34
Macrophages in myocardial infarction	34
Barriers and opportunities for gemcitabine in pancreatic cancer therapy	33